1.
Biemond BJ, Kesse-Adu R, Wahab E, Azbell RC, Boucher AA, Eleftheriou P, De Castro LM, Bergmann S, Hedrich WD, Wilson FR, Jung K, Araco M, Wang R, Shore PM, Kato GJ, Gordeuk VR. Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia. haematol [Internet]. 2020Sep.10 [cited 2026Mar.25];. Available from: https://haematologica.org/article/view/13403